BioTime (BTX) Misses Q1 EPS by 5c

BioTime (NYSE: BTX) reported Q1 EPS of ($0.19), $0.05 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $2.1 million versus the consensus estimate of $1.43 million.

For earnings history and earnings-related data on BioTime (BTX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Lockheed Martin frontrunner for $3.5B Ultra Maritime deal, sources say - FT
• Pembina joins proposed 1M bbl/day Alberta-to-coast pipeline plan